Par Pharmaceutical, Inc. recalls Gildess 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0,02 mg, USP), 21 count, (a) 3 blisters (NDC 0…
- Recall date
- September 27, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0120-2017
- FDA classification
- Class III
- Brand / firm
- Par Pharmaceutical, Inc.
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Subpotent Drug; Ethinyl Estradiol
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Gildess 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0,02 mg, USP), 21 count, (a) 3 blisters (NDC 0603-7607-48) and (b) 6 blisters (NDC 0603-7607-15), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811
Get recall alerts
Free email alert whenever Par Pharmaceutical, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Par Pharmaceutical, Inc.